Polydex Pharmaceuticals Ltd (POLXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -552 | -297 | -228 | -195 | 212 |
| Depreciation Amortization | 331 | 247 | 164 | 81 | 290 |
| Income taxes - deferred | 63 | N/A | N/A | N/A | N/A |
| Accounts receivable | 185 | N/A | N/A | N/A | 408 |
| Accounts payable and accrued liabilities | 105 | N/A | N/A | N/A | 247 |
| Other Working Capital | 74 | 186 | -289 | -16 | 763 |
| Other Operating Activity | -290 | 0 | 0 | 0 | -655 |
| Operating Cash Flow | $-85 | $136 | $-353 | $-130 | $1,265 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -152 | -143 | -101 | -25 | -286 |
| Purchase Of Investment | -19 | -14 | -9 | -5 | -56 |
| Investing Cash Flow | $-171 | $-157 | $-111 | $-30 | $-341 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -24 | -18 | -12 | -6 | -70 |
| Other Financing Activity | -61 | -46 | -30 | -15 | -52 |
| Financing Cash Flow | $-84 | $-63 | $-42 | $-21 | $-122 |
| Exchange Rate Effect | 55 | 68 | 48 | 49 | 143 |
| Beginning Cash Position | 1,314 | 1,314 | 1,314 | 1,314 | 370 |
| End Cash Position | 1,030 | 1,298 | 857 | 1,180 | 1,314 |
| Net Cash Flow | $-284 | $-16 | $-458 | $-135 | $944 |
| Free Cash Flow | |||||
| Operating Cash Flow | -85 | 136 | -353 | -130 | 1,265 |
| Capital Expenditure | -152 | -143 | -101 | -25 | -286 |
| Free Cash Flow | -236 | -7 | -455 | -155 | 979 |